Gritstone Asset Management’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

Gritstone Asset Management’s Portfolio EBAC Stock Details EBAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-55,952	Closed	-$565K	–	229
2022 Q4	$565K	Buy	+55,952	New	+$559K	0.72%	60

Gritstone Asset Management's EBAC Position: Q1 2023 in Review

Gritstone Asset Management sold out of European Biotech Acquisition Corp. Class A Ordinary Shares (EBAC) in Q1 2023, closing a stake of 55,952 shares — an estimated $565K sold.

Gritstone Asset Management first reported a position in EBAC in Q4 2022 and held it in 1 quarter. The position peaked at $565K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBAC as of Q1 2023.

Gritstone Asset Management reported no remaining European Biotech Acquisition Corp. Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Gritstone Asset Management sold 55,952 European Biotech Acquisition Corp. Class A Ordinary Shares shares in Q1 2023, an estimated $565K.
Gritstone Asset Management first reported a position in European Biotech Acquisition Corp. Class A Ordinary Shares in Q4 2022 and held it in 1 quarter.
Gritstone Asset Management's European Biotech Acquisition Corp. Class A Ordinary Shares position peaked at $565K in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Class A Ordinary Shares as of Q1 2023.

Based on Gritstone Asset Management's 13F filing for Q1 2023, filed 5 May 2023.